Screener
Biohaven BHVN Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Biohaven in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Biohaven’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001935979-26-000045
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Shareholders' (Deficit) Equity: | ||
| Preferred shares, no par value; 10,000,000 shares authorized, no shares issued and outstanding as of March 31, 2026 and December 31, 2025 | — | — |
| Common shares, no par value; 200,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 150,506,490 and 132,775,113 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 2,132,908 | 1,934,276 |
| Additional paid-in capital | 203,358 | 193,984 |
| Accumulated deficit | (2,215,068) | (2,084,536) |
| Accumulated other comprehensive income | 8,302 | 8,348 |
| Total shareholders' (deficit) equity | 129,500 | 52,072 |
| Total liabilities and shareholders' equity | $466,406 | $451,447 |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is Biohaven's total equity?
- Biohaven (BHVN) reported total equity of $129.5M in Q1 2026.
- How has Biohaven's total equity changed year-over-year?
- Biohaven's total equity decreased by 50.1% year-over-year, from $259.5M to $129.5M.
- What is the long-term trend for Biohaven's total equity?
- Over 5 years (2020 to 2025), Biohaven's total equity has grown at a 25.4% compound annual growth rate (CAGR), from $16.78M to $52.07M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Biohaven's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude